Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction: Medical and Cognitive Effects

NCT03065998 is registered in ClinicalTrials.gov with Ministry of Health, Israel as lead sponsor.

NCT NCT03065998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction: Medical and Cognitive Effects
Lead sponsor
Ministry of Health, Israel
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2017
Completion date
January 31, 2019
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse